So we have got an opportunity to focus on the common ground where, whatever the fuel source, less is more.

the current draft does not authorize any additional funding for FDA to take on these additional responsibilities

We are all very much onboard to try and increase that money.

The goal of this legislation might be well intentioned, but the drafting is flawed.

The question before us is simple: Are those current efforts enough to combat the problem, or should Congress legislate in this area?

The patent system plays a crucial role in promoting innovation by providing an incentive to inventors to make costly and time-consuming investments in research and development of new inventions.

I cannot support the bill before us today. It includes problematic language that does not move us forward.

Thank you, Mr. Chairman. And I thank you for having this hearing because I think it is very important.

Legislative solutions to address these vague, threatening, unsubstantiated, and often inaccurate letters have received bipartisan support, so I have hope that we can find a solution that all Members are able to support.

The Affordable Care Act has put Medicare on a path towards post-acute reform. However, there is still much more that needs to be done.

These things concern me a great deal.

I am amazed we don't have better information about patient outcome service user quality of care.